CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML
Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, prospective, randomized controlled clinical study comparing the efficacy and safety of CLAG+VEN and CLAG regimens in relapsed/refractory(r/r) AML.
Phase:
PHASE4
Details
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborators:
Affiliated Hospital of Guangdong Medical University Central People's Hospital of Zhanjiang Dongguan People's Hospital First Affiliated Hospital of Guangxi Medical University First People's Hospital of Foshan Foresea Life Insurance Guangzhou General Hospital Guangdong Second Provincial General Hospital Guangzhou First People's Hospital Guangzhou General Hospital of Guangzhou Military Command Guangzhou No.12 People's Hospital Guangzhou Panyu Central Hospital Guilin Medical University, China Hainan General Hospital Huizhou Municipal Central Hospital Jiangmen Central Hospital LiuZhou People's Hospital Maoming People's Hospital Peking University Shenzhen Hospital Second Affiliated Hospital of Guangzhou Medical University Shantou Central Hospital Shenzhen Hospital of Southern Medical University Shenzhen Second People's Hospital Southern Medical University, China Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Tungwah Hospital of Sun Yat-Sen University Yuebei People's Hospital Zhongshan People's Hospital, Guangdong, China ZhuHai Hospital